{
  "report_rows": [
    {
      "kpi": "Clear Aligner Volume (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~695K vs. cons 683K",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Non-GAAP Operating Margin (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~22.0% vs. cons ~21.5%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total Revenue (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~$1,060M vs. cons $1,051M",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Revenue (Q3 2026)",
      "prediction": "LOWER",
      "answer": "guide ~$1,025M mid vs. cons-implied ~$1,040M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "reaffirm ~$4,176M mid vs. cons $4,180M",
      "confidence": "HIGH"
    },
    {
      "kpi": "Non-GAAP Op Margin (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "reaffirm ~23.7% vs. cons ~23.7%",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": -2.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -4.5,
  "day5_path": "FADE",
  "day5_rationale": "FADE \u2014 Q3 guide cut pulls near-term estimates down post-print; sell-side models off next-Q; short-cover bid limits but does not reverse the drift",
  "day5_confidence": "MEDIUM"
}